| New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery | 09/05 09:00 | globenewswire.com |
| Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 08/26 09:00 | globenewswire.com |
| OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript | 08/11 07:17 | seekingalpha.com |
| OptiNose (OPTN) Reports Q2 Loss, Lags Revenue Estimates | 08/08 09:26 | zacks.com |
| Optinose Announces Reporting Date for Second Quarter 2024 Financial Results | 08/02 08:30 | globenewswire.com |
| 7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million | 07/02 16:27 | investorplace.com |
| Expanded Access to XHANCE with Addition to National Commercial Formularies | 06/27 07:00 | globenewswire.com |
| OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript | 05/17 20:55 | seekingalpha.com |
| Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ | 05/17 12:00 | globenewswire.com |
| OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates | 05/14 09:11 | zacks.com |